These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

58 related articles for article (PubMed ID: 18796691)

  • 1. PET/CT for monitoring therapy response in breast cancer patients with bone metastases.
    Beheshti M; Langsteger W
    Radiology; 2008 Oct; 249(1):389-90; author reply 390. PubMed ID: 18796691
    [No Abstract]   [Full Text] [Related]  

  • 2. Fusion of metabolic function and morphology: sequential [18F]fluorodeoxyglucose positron-emission tomography/computed tomography studies yield new insights into the natural history of bone metastases in breast cancer.
    Du Y; Cullum I; Illidge TM; Ell PJ
    J Clin Oncol; 2007 Aug; 25(23):3440-7. PubMed ID: 17592153
    [TBL] [Abstract][Full Text] [Related]  

  • 3. MRI and PET/CT of patients with bone metastases from breast carcinoma.
    Grankvist J; Fisker R; Iyer V; Fründ ET; Simonsen C; Christensen T; Stenbygaard L; Ewertz M; Larsson EM
    Eur J Radiol; 2012 Jan; 81(1):e13-8. PubMed ID: 21227614
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Bone and peritoneal metastasis of breast carcinoma: findings on fluorine-18 fluorodeoxyglucose positron emission tomography/computed tomography.
    Ozcan Kara P; Kara T; Kara Gedik G; Sari O
    Rev Esp Med Nucl; 2011; 30(3):180-1. PubMed ID: 21334777
    [No Abstract]   [Full Text] [Related]  

  • 5. Detection of occult bone metastases from head and neck squamous cell carcinoma: impact of positron emission tomography computed tomography with fluorodeoxyglucose F 18.
    Basu D; Siegel BA; McDonald DJ; Nussenbaum B
    Arch Otolaryngol Head Neck Surg; 2007 Aug; 133(8):801-5. PubMed ID: 17709620
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Detection of hematogenous bone metastasis in cervical cancer: 18F-fluorodeoxyglucose-positron emission tomography versus computed tomography and magnetic resonance imaging.
    Liu FY; Yen TC; Chen MY; Lai CH; Chang TC; Chou HH; Hong JH; Chen YR; Ng KK
    Cancer; 2009 Dec; 115(23):5470-80. PubMed ID: 19739235
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bone imaging in metastatic breast cancer.
    Hamaoka T; Madewell JE; Podoloff DA; Hortobagyi GN; Ueno NT
    J Clin Oncol; 2004 Jul; 22(14):2942-53. PubMed ID: 15254062
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A meta-analysis of ¹⁸FDG-PET-CT, ¹⁸FDG-PET, MRI and bone scintigraphy for diagnosis of bone metastases in patients with lung cancer.
    Qu X; Huang X; Yan W; Wu L; Dai K
    Eur J Radiol; 2012 May; 81(5):1007-15. PubMed ID: 21354739
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The detection of bone metastases in patients with high-risk prostate cancer: 99mTc-MDP Planar bone scintigraphy, single- and multi-field-of-view SPECT, 18F-fluoride PET, and 18F-fluoride PET/CT.
    Even-Sapir E; Metser U; Mishani E; Lievshitz G; Lerman H; Leibovitch I
    J Nucl Med; 2006 Feb; 47(2):287-97. PubMed ID: 16455635
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [(11)C]Choline positron emission tomography/computed tomography for staging and restaging of patients with advanced prostate cancer.
    Tuncel M; Souvatzoglou M; Herrmann K; Stollfuss J; Schuster T; Weirich G; Wester HJ; Schwaiger M; Krause BJ
    Nucl Med Biol; 2008 Aug; 35(6):689-95. PubMed ID: 18678354
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Expert consensus on the diagnosis and treatment of bone metastasis and skeletal related events in breast cancer patients].
    Collaborating study group on breast cancer bone metastasis
    Zhonghua Zhong Liu Za Zhi; 2009 Feb; 31(2):156-9. PubMed ID: 19538898
    [No Abstract]   [Full Text] [Related]  

  • 12. PET/CT study performed after an oral administration of 18F-fluoride.
    Zacchi SR; Valadares AA; Duarte PS; Sapienza MT; Buchpiguel CA
    Clin Nucl Med; 2013 Dec; 38(12):1012-4. PubMed ID: 24152650
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Positron emission tomography/computed tomography with 18fluoro-deoxyglucose in the detection of local recurrence and distant metastases of pediatric sarcoma.
    Arush MW; Israel O; Postovsky S; Militianu D; Meller I; Zaidman I; Sapir AE; Bar-Shalom R
    Pediatr Blood Cancer; 2007 Dec; 49(7):901-5. PubMed ID: 17252575
    [TBL] [Abstract][Full Text] [Related]  

  • 14. "One-stop-shop" staging: should we prefer FDG-PET/CT or MRI for the detection of bone metastases?
    Heusner T; Gölitz P; Hamami M; Eberhardt W; Esser S; Forsting M; Bockisch A; Antoch G
    Eur J Radiol; 2011 Jun; 78(3):430-5. PubMed ID: 19945240
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Osteopoikilosis masquerading as osseous metastases in breast cancer.
    McArdle A; O'Riordan C; Connolly EM
    Breast Cancer; 2014 Nov; 21(6):765-8. PubMed ID: 21990037
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Detection of metastatic bone lesions in breast cancer patients: fused (18)F-Fluoride-PET/MDCT has higher accuracy than MDCT. Preliminary experience.
    Piccardo A; Altrinetti V; Bacigalupo L; Puntoni M; Biscaldi E; Gozza A; Cabria M; Iacozzi M; Pasa A; Morbelli S; Villavecchia G; DeCensi A
    Eur J Radiol; 2012 Oct; 81(10):2632-8. PubMed ID: 22227259
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bone metastases in patients with neuroendocrine tumor: 68Ga-DOTA-Tyr3-octreotide PET in comparison to CT and bone scintigraphy.
    Putzer D; Gabriel M; Henninger B; Kendler D; Uprimny C; Dobrozemsky G; Decristoforo C; Bale RJ; Jaschke W; Virgolini IJ
    J Nucl Med; 2009 Aug; 50(8):1214-21. PubMed ID: 19617343
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Circulating tumor cells and [18F]fluorodeoxyglucose positron emission tomography/computed tomography for outcome prediction in metastatic breast cancer.
    De Giorgi U; Valero V; Rohren E; Dawood S; Ueno NT; Miller MC; Doyle GV; Jackson S; Andreopoulou E; Handy BC; Reuben JM; Fritsche HA; Macapinlac HA; Hortobagyi GN; Cristofanilli M
    J Clin Oncol; 2009 Jul; 27(20):3303-11. PubMed ID: 19451443
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prostate carcinoma: diffusion-weighted imaging as potential alternative to conventional MR and 11C-choline PET/CT for detection of bone metastases.
    Luboldt W; Küfer R; Blumstein N; Toussaint TL; Kluge A; Seemann MD; Luboldt HJ
    Radiology; 2008 Dec; 249(3):1017-25. PubMed ID: 18849502
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Results and consequence of the systematic staging imaging at the time of the breast cancer diagnosis.
    Mailliez A; Turpin A; Vennin P; Bonneterre J
    Breast; 2013 Aug; 22(4):555. PubMed ID: 23602423
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 3.